70.22.Z - Head office activities and management consultancy
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
46.46.Z - Wholesale trade of pharmaceutical and medical products
47.74.Z - Retail sale of medical and orthopedic products
63.99.Z - Services related to computing infrastructure, data processing, website management (hosting), and other information services
69.20.Z - Accounting, bookkeeping and tax consultancy
72.19.Z - Scientific research and development activities
74.90.Z - Other professional, scientific and technical activities, not elsewhere classified
82.99.Z - Other business support activities, not elsewhere classified
2020 | 2021 | 2022 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss) | -3,6 | -30,2 | -10,3 | 66 |
EBITDA | -2,1 | -30,2 | -9,6 | 68,3 |
Short time liabilities | 16,8 | 17,5 | 17,2 | -1,6 |
Equity capital | 161 | 130,8 | 120,6 | -7,8 |
Operating profit (EBIT) | -2,1 | -30,2 | -9,6 | 68,3 |
Assets | 177,8 | 148,3 | 137,8 | -7,1 |
Net profit (loss) | -3,6 | -30,2 | -10,3 | 66 |
Cash | 108,2 | 86,1 | 62,7 | -27,2 |
Net income from sale | 100,5 | 69,1 | 38,9 | -43,8 |
Liabilities and provisions for liabilities | 16,8 | 17,5 | 17,2 | -1,6 |
Working assets | 177,8 | 148,3 | 137,8 | -7,1 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | -2,2 | -23,1 | -8,5 | 14,6 |
Equity capital to total assets | 90,6 | 88,2 | 87,5 | -0,7 |
Gross profit margin | -3,6 | -43,7 | -26,4 | 17,3 |
EBITDA Margin | -2,1 | -43,7 | -24,6 | 19,1 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 61 | 92 | 162 | 70 |
Current financial liquidity indicator | 6.4528093338012695 | 4.969576835632324 | 7.9967875480651855 | 3 |
Net dept to EBITDA | 52.36994934082031 | 2.8549604415893555 | 6.55047082901001 | 3,7 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane